Enfusion Inc (ENFN)
10.07
+0.38
(+3.92%)
USD |
NYSE |
Nov 14, 12:18
Enfusion Cash from Investing (Quarterly): -2.775M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -2.775M |
June 30, 2024 | -5.706M |
March 31, 2024 | -2.748M |
December 31, 2023 | -2.295M |
September 30, 2023 | -2.607M |
June 30, 2023 | -2.219M |
March 31, 2023 | -2.55M |
December 31, 2022 | -1.746M |
Date | Value |
---|---|
September 30, 2022 | -0.922M |
June 30, 2022 | -2.092M |
March 31, 2022 | -3.171M |
December 31, 2021 | -1.641M |
September 30, 2021 | -1.972M |
June 30, 2021 | -2.049M |
March 31, 2021 | -2.352M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-5.706M
Minimum
Jun 2024
-0.922M
Maximum
Sep 2022
-2.456M
Average
-2.295M
Median
Dec 2023
Cash from Investing (Quarterly) Benchmarks
F5 Inc | -5.743M |
Cognizant Technology Solutions Corp | -1.25B |
Castellum Inc | -0.0545M |
BM Technologies Inc | -1.433M |
Marti Technologies Inc | -- |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 16.16M |
Cash from Financing (Quarterly) | -0.014M |
Free Cash Flow | 21.07M |
Free Cash Flow Per Share (Quarterly) | 0.1038 |
Free Cash Flow to Equity (Quarterly) | 13.39M |
Free Cash Flow to Firm (Quarterly) | 13.39M |
Free Cash Flow Yield | 1.76% |